@article{article, title  = {{454 A phase II study of vinorebline (VRL) alterning oral and intravenous (IV) plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC)}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2003}},

 month = {{9}},

 author = {{Verrill M and Serin D and Jones A and Delozier T and Coleman R}},

 doi = {{10.1016/s1359-6349(03)90486-1}},

 volume = {{1}},

 journal = {{European Journal of Cancer Supplements}},

 issue = {{5}},

 pages = {{S138-S139}},

 note = {{Accessed on 2025/10/10}}}